Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma
暂无分享,去创建一个
S. Ansell | S. Markovic | W. Hogan | D. Inwards | I. Micallef | L. Porrata | P. Johnston
[1] S. Ansell,et al. Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[2] E. Jantunen,et al. Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: potential implications for apheresis and graft composition. , 2012, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[3] A. Dietz,et al. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma. , 2011, Blood.
[4] Steven J. M. Jones,et al. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. , 2010, The New England journal of medicine.
[5] P. Went,et al. Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores , 2010, Leukemia & lymphoma.
[6] A. Feldman,et al. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. , 2009, Blood.
[7] Srinivas Nagaraj,et al. Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.
[8] L. Staudt,et al. Stromal gene signatures in large-B-cell lymphomas. , 2008, The New England journal of medicine.
[9] S. Ansell,et al. Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[10] K. Gupta,et al. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer , 2007, Nature Medicine.
[11] Sigrid Stroobants,et al. Revised response criteria for malignant lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[12] S. Ansell,et al. Targeting B-lymphocyte stimulator/B-cell activating factor and a proliferation-inducing ligand in hematologic malignancies. , 2006, Clinical lymphoma & myeloma.
[13] A. Dispenzieri,et al. The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myeloma , 2004, Leukemia.
[14] S. Ansell,et al. Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma , 2004, Bone Marrow Transplantation.
[15] J. Talmadge. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. , 2003, International immunopharmacology.
[16] S. Ansell,et al. Early lymphocyte recovery post‐autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease , 2002, British journal of haematology.
[17] J. Armitage,et al. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. , 1998, The New England journal of medicine.
[18] K. Ino,et al. Restoration of T and NK cell function in GM-CSF mobilized stem cell products from breast cancer patients by monocyte depletion , 1997, Bone Marrow Transplantation.
[19] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[20] L. Porrata,et al. Autograft Monocytes: The Bad Humors of Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation , 2011 .
[21] A. Schwarer,et al. Higher infused lymphocyte dose predicts higher lymphocyte recovery, which in turn, predicts superior overall survival following autologous hematopoietic stem cell transplantation for multiple myeloma. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[22] Olker,et al. A PROGNOSTIC SCORE FOR ADVANCED HODGKIN ’ S DISEASE , 2000 .
[23] K. Ino,et al. Immunoregulatory cytokines in bone marrow and peripheral blood stem cell products , 1999, Bone Marrow Transplantation.
[24] D.,et al. Regression Models and Life-Tables , 2022 .